Asklepios BioPharmaceutical
Adam Okinaga is a Research Associate II at Asklepios BioPharmaceutical, Inc. (AskBio) since April 2022, focusing on research-grade plasmid DNA manufacturing for preclinical rAAV gene therapy research. Adam's role includes contributing to process development, participating in technology transfer of neDNA™ manufacturing, advising and training lab members, managing lab operations, and serving as a subject matter expert in Benchling electronic lab notebook usage. Previously, Adam was a Research Assistant at Duke University School of Medicine, studying the role of astrocytes in synaptic connectivity under Dr. Cagla Eroglu and conducted independent microbiology research at the University of South Carolina School of Medicine Greenville under Dr. Jennifer Grier. Adam also has experience as a Machine Assembler with Automation Engineering Company. Adam holds a Bachelor of Science in Biochemistry and Molecular Biology from the University of South Carolina.
This person is not in any teams
This person is not in any offices
Asklepios BioPharmaceutical
1 followers
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.